Has Rachel Fields received payments from drug or device companies?

Yes. Drug and device makers reported $2,521 in general payments to Rachel Fields across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachel Fields did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachel Fields come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachel Fields

Acute Care · Lewes, DENPI 1336535715

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Medtronic at 32.6% of the total. Reporting peaked in 2022 at $1,283 and has fallen 99.1% since, to $11 in 2024. Among acute care clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,521in general payments, 2019–2025

Across 72 payments — averaging $35.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$823
AstraZeneca$336
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$256
Boston Scientific$229
Biotronik Inc.$114
Novartis$102
plus $661 from 11 others

What the payments were for

Food & beverage$2,521100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	8	$823
AstraZeneca	13	$336
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	5	$256
Boston Scientific	2	$229
Biotronik Inc.	6	$114
Novartis	6	$102
Amgen	4	$86
Cardiovascular Systems Inc.	1	$85
Johnson & Johnson	5	$84
Daiichi Sankyo Inc.	5	$80
Novo Nordisk	4	$72
Amarin Pharma, Inc.	3	$62
Esperion Therapeutics, Inc.	2	$50
E.r. Squibb & Sons, L.L.C.	3	$44
Vifor Pharma, Inc.	1	$36
Bayer	2	$31
Merck	2	$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,521 in reported general payments places this provider in the 90th percentile of 26 acute care providers in Delaware.

See all acute care providers in Delaware →

Medicare billing

Part B allowed, 2024

$4,874

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Xtampza ErOxycodone Myristate	24	$7,644
Sucralfate	20	$3,453
Pregabalin	38	$803
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$696
Warfarin Sodium	61	$532
Duloxetine Hcl	14	$493
Lorazepam	16	$472
Nitroglycerin	14	$440
Trazodone Hcl	12	$420
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	18	$418
Hydralazine Hcl	15	$413
Olanzapine	15	$408
Ipratropium-AlbuterolIpratropium/Albuterol Sulfate	13	$395
Levothyroxine Sodium	26	$373
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	13	$343

Paid to pharmacies, not to this prescriber.

Other acute care in Lewes

Pamela BlondinLewes$6K
Thomas TrobianoLewes$787
Jill PetroneLewes$265
Laura TolsonLewes$229
Elizabeth FrederickLewes$28
Jeannette DaumSeaford$6K
Shanna AmorosoNewark$2K
Youngja MooreNewark$1K
Andrew VincentWilmington$1K
Matthew FranklinNewark$1K

See the full list for Delaware →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →